FDA recall, , Moderate risk
Tissue Transplant Technology Bone
Bone products could cause contamination or spread of disease.
Recall ended Sep 22, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Tissue Transplant Technology, Ltd. began a recall of Bone products on November 26, 2024, because the products were processed in a manner that could cause contamination, cross-contamination, or the introduction, transmission, or spread of communicable disease.
The FDA added the recall to its Enforcement Report on September 22, 2026, and listed it in its weekly enforcement report on September 30, 2026. The products were distributed in Florida, Maryland, New Jersey, New York, Ohio, Pennsylvania, Texas and Washington.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Bone
Recall details
- Company began the recall
- Company
- Tissue Transplant Technology, Ltd.
- Hazard
- Contamination
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99920
- Recall number
- B-0254-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
